Severe COVID-19 risk factors
Severe COVID-19 risk factors: The course and severity of COVID-19 in individual patients is largely influenced by the interaction between…
Infection/Disease
The unusual suspects: Rare disease webinar
The unusual suspects: Rare disease in everyday medicine from The Royal Society of Medicine. Date and time: Wed 24 Feb…
Monday 22 February is World Encephalitis Day
World Encephalitis Day is the global awareness day for people who have been directly or indirectly affected by encephalitis. Founded by…
How inflammatory signalling molecules contribute to carcinogenesis
How inflammatory signalling molecules contribute to carcinogenesis: A team of MedUni Vienna researchers led by Johannes A. Schmid at the…
When the time comes
Families of older people dying of progressive chronic disease often feel insufficiently informed about the course of the illness, so…
Resurgence of Ebola in Butembo, North Kivu DRC
Resurgence of Ebola in Butembo, North Kivu in the Democratic Republic of the Congo: Brazzaville – The Ministry of Health of the…
New drug development using Nature’s strategies
Oxytocin/vasopressin receptors are typical examples of so-called G protein-coupled receptors – the most successful drug target class. The oxytocin and…
The invisible killer lurking in our consumer products
Our consumer products, such as food, cosmetics and clothes, might be filled with nanomaterials – unbeknownst to us. The use…
Genetic screening before prescribing
Genetic screening before prescribing could benefit millions: Four million UK patients could benefit annually from genetic testing before being prescribed…
New COVID-19 variants fuelling Africa’s second wave
COVID-19 cases and deaths are surging in Africa as new, more contagious variants of the virus spread to additional countries.…